Apex Biotechnology Corp. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 555.348 million compared to TWD 478.449 million a year ago. Net income was TWD 70.426 million compared to TWD 22.104 million a year ago. Basic earnings per share was TWD 0.71 compared to TWD 0.22 a year ago. Diluted earnings per share was TWD 0.63 compared to TWD 0.22 a year ago. For the nine months, sales was TWD 1,523.665 million compared to TWD 1,323.240 million a year ago. Net income was TWD 132.295 million compared to TWD 40.853 million a year ago. Basic earnings per share was TWD 1.33 compared to TWD 0.41 a year ago. Diluted earnings per share was TWD 1.22 compared to TWD 0.41 a year ago.